Alligator Bioscience: New Clinical Study Funded - Redeye
Bildkälla: Stockfoto

Alligator Bioscience: New Clinical Study Funded - Redeye

This morning, Alligator announced the launch of a new investigator-sponsored phase II/III trial with mitazalimab in biliary tract cancer. Redeye sees the new trial as improving the investment case significantly.

This morning, Alligator announced the launch of a new investigator-sponsored phase II/III trial with mitazalimab in biliary tract cancer. Redeye sees the new trial as improving the investment case significantly.
Börsvärldens nyhetsbrev